Effect of Cardiovascular Autonomic Neuropathy on AKI and Outcomes in Isolated CABG Surgery
NCT ID: NCT07254468
Last Updated: 2025-11-28
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
ACTIVE_NOT_RECRUITING
884 participants
OBSERVATIONAL
2021-11-04
2025-12-23
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Preoperative data including demographics, comorbidities, kidney function tests, hemodynamic parameters, and baseline regional cerebral oxygen saturation (rSO2) will be recorded. Intraoperative data will include hemodynamics, urine output, blood gases, cardiopulmonary bypass and aortic cross-clamp times, cardioplegia details, number of coronary anastomoses, and rSO2 changes at defined time points.
Postoperatively, kidney function, neurological status, mechanical ventilation duration, inotropic drug use, transfusion requirements, complications, ICU and hospital length of stay, and mortality will be evaluated. Acute Kidney Injury will be classified according to KDIGO criteria.
The primary objective is to analyze the effect of CAN on AKI. Secondary objectives include assessing the impact of CAN on other clinical outcomes and exploring the relationship between CAN and intraoperative cerebral oxygen changes.
This study has been approved by the Acıbadem University and Acıbadem Healthcare Institutions Medical Research Ethics Committee (ATADEK) and will be conducted following ethical principles and good clinical practice.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Effect of Remote Ischemic Preconditioning on the Incidence of Acute Kidney Injury in Patients Undergoing Coronary Artery Bypass Graft Surgery
NCT02981680
Cardiac Rehabilitation in Coronary Artery Bypass Graft Surgery
NCT07006441
Autonomic State, Cardiovascular Control and Outcomes in Coronary Surgery
NCT03169608
REGIONAL ANALGESIA TECHNIQUES FOR EFFECTIVE RECOVERY TO CORONARY ARTERY BYPASS SURGERIES: A RETROSPECTİVE STUDY IN A SINGLE CENTER EXPERIENCE
NCT05282303
Perfusion Related Evaluation of Systemic and Renal Vulnerability to Events in CABG
NCT07085286
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Study Population:
Adults aged 18 years or older scheduled for elective isolated CABG surgery with planned ECC.
Inclusion Criteria:
Elective isolated CABG surgery Age ≥18 years
Exclusion Criteria:
Emergency or revision surgeries
Orthopedic conditions preventing standing tests
Chronic respiratory diseases affecting test reliability (COPD, asthma, chronic bronchitis)
Uncontrolled hypertension
Use of antiarrhythmic drugs affecting heart rate-based tests
Chronic kidney failure
Preoperative Assessment:
CAN diagnosis using Valsalva maneuver, sitting-to-standing test, and cold/heat test (positive if ≥2 tests are abnormal).
Collection of demographic data, comorbidities, laboratory tests (BUN, creatinine, GFR, ), hemodynamic parameters, and baseline regional cerebral oxygen saturation (rSO2).
Intraoperative Monitoring:
Hemodynamic parameters, urine output, blood gases, cardiopulmonary bypass and aortic cross-clamp times, and number of coronary anastomoses recorded.
Regional cerebral oxygen saturation (rSO2) continuously monitored during ECC, with values recorded for analysis but not used for clinical decisions.
Mean arterial pressure maintained at 60-100 mmHg; crystalloids infused at ≥100 ml/h; ephedrine administered if MAP \<60 mmHg.
Postoperative Evaluation:
Kidney function monitored at 24h, 48h, and 7 days postoperatively using KDIGO criteria.
Evaluation of neurological outcomes, mechanical ventilation duration, inotropic support, transfusion requirements, postoperative complications (reoperation, mediastinitis, myocardial infarction), ICU and hospital length of stay, and mortality.
Study Objectives:
Primary: Assess the effect of CAN on AKI incidence.
Secondary: Evaluate CAN's impact on other clinical outcomes
Ethics and Compliance:
Approved by Acıbadem University and Acıbadem Healthcare Institutions Medical Research Ethics Committee (ATADEK), approval number 2020-21/13.
Conducted according to ethical principles and Good Clinical Practice (GCP) standards.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
CABG Surgery Cohort
This cohort includes adult patients undergoing isolated coronary artery bypass graft (CABG) surgery with extracorporeal circulation (ECC). Each participant is evaluated preoperatively for cardiovascular autonomic neuropathy (CAN) using the Valsalva maneuver, sitting-to-standing test, and cold/heat test. Demographic, hemodynamic, and laboratory data, as well as regional cerebral oxygen saturation (rSO₂), are recorded. Postoperative outcomes include acute kidney injury (AKI) assessed by KDIGO criteria, complications, ICU and hospital stay, and mortality. No intervention is applied.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Scheduled for elective isolated Coronary Artery Bypass Graft (CABG) surgery with planned extracorporeal circulation (ECC)
Provide informed consent
Exclusion Criteria
Severe chronic respiratory disease (COPD, asthma, chronic bronchitis) affecting test reliability
Uncontrolled hypertension
Use of antiarrhythmic drugs affecting heart rate-based autonomic tests
Orthopedic or neurological conditions preventing standing tests
\-
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Akdeniz University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Emel Gunduz
Associate Professor of Anesthesiology, Akdeniz University, Antalya, Turkey
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Akdeniz University, Faculty of Medicine, Department of Anesthesiology and Reanimation
Antalya, Antalya, Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol, Statistical Analysis Plan, and Informed Consent Form
Related Links
Access external resources that provide additional context or updates about the study.
Systematic review on the association between diabetic peripheral neuropathy and cardiac autonomic neuropathy.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CAN_AKI_STUDY
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.